All In Biotech

Drug Trial Radar · NCT07845487

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Induction and Maintenance Therapy With PALI-2108 in Participants With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 204 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

204

Planned (sponsor's estimate)

Start

Aug 28, 2026

Primary completion

Oct 2027

Study completion Jun 2028

Sponsor

Lead sponsor
Palisade BioIndustry
Sponsor type
Industry
First posted
Sep 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a placebo to see how well it works, how safe it is, and how the body responds to it.

Conditions

  • Ulcerative Colitis (UC)
  • Severe Ulcerative Colitis
  • Moderate Ulcerative Colitis

Interventions

  • PALI-2108Drug

    Oral Dose

  • PALI-2108Drug

    Oral Dose

  • PlaceboDrug

    Oral Dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with clinical remission using the 3-component modified Mayo Score (mMS) at Week 12.Time frame: Week 12

Locations

114 sites in 12 countries. Site status is shown where the registry gives one.

  • Site US-022

    Sun City, Arizona · Recruiting

  • Site US-018

    San Diego, California · Recruiting

  • Site US-028

    Bristol, Connecticut · Recruiting

  • Site US-026

    Orlando, Florida · Recruiting

  • Site US-005

    Des Plaines, Illinois · Recruiting

  • Site US-007

    Glenview, Illinois · Recruiting

  • Site US-020

    Gurnee, Illinois · Recruiting

  • Site US-008

    Baton Rouge, Louisiana · Recruiting

  • Site US-011

    Mandeville, Louisiana · Recruiting

  • Site US-010

    Tupelo, Mississippi · Recruiting

  • Site US-006

    St Louis, Missouri · Recruiting

  • Site US-014

    Clifton, New Jersey · Recruiting

  • Site US-002

    Albany, New York · Recruiting

  • Site US-016

    Rochester, New York · Recruiting

  • Site US-025

    Brunswick, Ohio · Recruiting

  • Site US-023

    Dayton, Ohio · Recruiting

  • Site US-027

    Westlake, Ohio · Recruiting

  • Site US-019

    Providence, Rhode Island · Recruiting

  • Site US-003

    Cordova, Tennessee · Recruiting

  • Site US-024

    Garland, Texas · Recruiting

  • Site US-009

    Georgetown, Texas · Recruiting

  • Site US-030

    Houston, Texas · Recruiting

  • Site US-015

    Lubbock, Texas · Recruiting

  • Site US-017

    Mansfield, Texas · Recruiting

  • Site US-001

    Southlake, Texas · Recruiting

  • Site US-004

    Tyler, Texas · Recruiting

  • Site US-013

    Richmond, Virginia · Recruiting

  • Site US-021

    Bellevue, Washington · Recruiting

  • Site US-029

    Tacoma, Washington · Recruiting

  • Site US-012

    Milwaukee, Wisconsin · Recruiting

  • Site CA-005

    Calgary, Alberta, Canada · Not yet recruiting

  • Site CA-004

    Edmonton, Alberta, Canada · Not yet recruiting

  • Site CA-006

    Greater Sudbury, Ontario, Canada · Not yet recruiting

  • Site CA-003

    London, Ontario, Canada · Not yet recruiting

  • Site CA-002

    Scarborough Village, Ontario, Canada · Not yet recruiting

  • Site CA-007

    Montreal, Quebec, Canada · Not yet recruiting

  • Site CA-001

    Montreal, Quebec, Canada · Not yet recruiting

  • Site CZ-005

    Brno, Czechia · Not yet recruiting

  • Site CZ-002

    Brno, Czechia · Not yet recruiting

  • Site CZ-008

    Havířov, Czechia · Not yet recruiting

Showing 40 of 114 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.